chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tongue discomfort, Vaccination site bruising
Clinical narrative: tongue and lips are swollen,  lips are cracked with some bleeding.; tongue and lips are swollen,  lips are cracked with some bleeding.; tongue and lips are swollen,  lips are cracked with some bleeding.; lips are cracked with some bleeding; very deep purple color, about the size of a dime, around the injection site.",; Tongue is very painful - feels like it got severely burnt; Tongue is very painful - feels like it got severely burnt; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 57-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8731) via an unspecified route of administration, administered in arm right on 20Apr2021 08:45 (at the age of 56-year-old) at dose 1, single for covid-19 immunisation. Medical history included high blood pressure and cholesterol, Bicuspid aortic valve. Patient had Known allergies with erythromycin. Concomitant medications included amlodipine (AMLODI-PINE) 2.5 mg; rosuvastatin (ROSUVASTATIN) 20mg; aspirin [acetylsalicylic acid] (ASPIRIN [ACETYL-SALICYLIC ACID]) 81mg, all taken for an unspecified indication, start and stop date were not reported, patient received these medications in two weeks. Patient did not have other vaccine in four weeks. Patient did not have covid prior vaccination and was not tested for covid post vaccination. On 20Apr2021 18:00 the patient experienced adverse event: tongue and lips are swollen, lips are cracked with some bleeding. Tongue is very painful - feels like it got severely burnt. Nothing soothes nor dulls the pain. This presented the evening of 20Apr2021. It hasn't improved over these past three days. If no improvement by 26Apr, I will seek medical intervention. Also very deep purple color, about the size of a dime, around the injection site. Patient did not receive treatment for the adverse events. Outcome of the events was not resolved.  Follow-up (22Oct2021): Follow-up attempts are completed. No further information is expected.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Headache
Clinical narrative: In the earlier morning on 16Jun2021 between 2am to 4am he felt pain and burning on chest; After 1st vaccination, patient felt headaches the next day and drank 2 tylenol pills; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 14Jun2021 at 18:30 as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not take any concomitant medications. On 08Feb2021, the patient underwent nasal swab test and the result was negative. On 15Jun2021, the patient felt headaches. On 16Jun2021 early morning between 02:00 to 04:00, the patient experienced pain and burning on chest. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were taken as a result of the evets headache, pain and burning on chest and included 2 tylenol pills which the patient drank. Since the vaccination, on an unknown date in 2021, the patient had been tested for COVID-19 via nasal swab test and the result was negative. The clinical outcome of the events headaches, pain and burning on chest were resolved on an unknown date in Jun2021.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Headache, SARS-CoV-2 test
Clinical narrative: In the earlier morning on 16Jun2021 between 2am to 4am he felt pain and burning on chest; After 1st vaccination, patient felt headaches the next day and drank 2 tylenol pills; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 14Jun2021 at 18:30 as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not take any concomitant medications. On 08Feb2021, the patient underwent nasal swab test and the result was negative. On 15Jun2021, the patient felt headaches. On 16Jun2021 early morning between 02:00 to 04:00, the patient experienced pain and burning on chest. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were taken as a result of the evets headache, pain and burning on chest and included 2 tylenol pills which the patient drank. Since the vaccination, on an unknown date in 2021, the patient had been tested for COVID-19 via nasal swab test and the result was negative. The clinical outcome of the events headaches, pain and burning on chest were resolved on an unknown date in Jun2021.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthma, Condition aggravated, Pyrexia
Clinical narrative: Asthma Exacerbation
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthma, Autopsy
Clinical narrative: Asthma Exacerbation
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rash, Weight
Clinical narrative: He states he developed red itchy rash on bilateral inner thighs & right arm the day after he had Covid Vaccine #1. Vaccinated in Left arm. He has been using Cortisone Creme. Rash on right arm is now faint pink & the rash on inner thighs is improving. He stated that he "Self reported" to the CDC, Pfiser & contacted his PCP.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rash, Rash erythematous, Rash pruritic
Clinical narrative: He states he developed red itchy rash on bilateral inner thighs & right arm the day after he had Covid Vaccine #1. Vaccinated in Left arm. He has been using Cortisone Creme. Rash on right arm is now faint pink & the rash on inner thighs is improving. He stated that he "Self reported" to the CDC, Pfiser & contacted his PCP.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Alanine aminotransferase normal, Albumin globulin ratio, Antinuclear antibody, Arthralgia, Aspartate aminotransferase normal
Clinical narrative: Dizziness; Tiredness; Irregular heartbeat; Joint pain; Chill; Blood in urine; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 16:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 16Apr2021 at 08:30 the patient experienced dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit and the events resulted in emergency room/department visit or urgent care. On same day, the patient underwent test for heart rate and the result was irregular heartbeat. The clinical outcome of the events dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bacterial test, Basophil count normal, Basophil percentage increased, Blood albumin normal, Blood alkaline phosphatase normal
Clinical narrative: Dizziness; Tiredness; Irregular heartbeat; Joint pain; Chill; Blood in urine; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 16:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 16Apr2021 at 08:30 the patient experienced dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit and the events resulted in emergency room/department visit or urgent care. On same day, the patient underwent test for heart rate and the result was irregular heartbeat. The clinical outcome of the events dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood bilirubin, Blood bilirubin normal, Blood calcium normal, Blood chloride normal, Blood creatinine normal
Clinical narrative: Dizziness; Tiredness; Irregular heartbeat; Joint pain; Chill; Blood in urine; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 16:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 16Apr2021 at 08:30 the patient experienced dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit and the events resulted in emergency room/department visit or urgent care. On same day, the patient underwent test for heart rate and the result was irregular heartbeat. The clinical outcome of the events dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood folate normal, Blood glucose normal, Blood pH normal, Blood potassium normal, Blood sodium normal
Clinical narrative: Dizziness; Tiredness; Irregular heartbeat; Joint pain; Chill; Blood in urine; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 16:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 16Apr2021 at 08:30 the patient experienced dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit and the events resulted in emergency room/department visit or urgent care. On same day, the patient underwent test for heart rate and the result was irregular heartbeat. The clinical outcome of the events dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood testosterone normal, Blood thyroid stimulating hormone decreased, Blood urea nitrogen/creatinine ratio, Blood urea normal, Blood urine present
Clinical narrative: Dizziness; Tiredness; Irregular heartbeat; Joint pain; Chill; Blood in urine; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 16:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 16Apr2021 at 08:30 the patient experienced dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit and the events resulted in emergency room/department visit or urgent care. On same day, the patient underwent test for heart rate and the result was irregular heartbeat. The clinical outcome of the events dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Carbon dioxide normal, Cardiolipin antibody, Chest pain, Chromaturia, Cortisol abnormal
Clinical narrative: Dizziness; Tiredness; Irregular heartbeat; Joint pain; Chill; Blood in urine; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 16:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 16Apr2021 at 08:30 the patient experienced dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit and the events resulted in emergency room/department visit or urgent care. On same day, the patient underwent test for heart rate and the result was irregular heartbeat. The clinical outcome of the events dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Culture urine, Dizziness, Double stranded DNA antibody, Dyspepsia, Echocardiogram normal
Clinical narrative: Dizziness; Tiredness; Irregular heartbeat; Joint pain; Chill; Blood in urine; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 16:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 16Apr2021 at 08:30 the patient experienced dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit and the events resulted in emergency room/department visit or urgent care. On same day, the patient underwent test for heart rate and the result was irregular heartbeat. The clinical outcome of the events dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram ambulatory normal, Electrocardiogram normal, Eosinophil count normal, Eosinophil percentage increased, Fatigue
Clinical narrative: Dizziness; Tiredness; Irregular heartbeat; Joint pain; Chill; Blood in urine; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 16:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 16Apr2021 at 08:30 the patient experienced dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit and the events resulted in emergency room/department visit or urgent care. On same day, the patient underwent test for heart rate and the result was irregular heartbeat. The clinical outcome of the events dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Globulin, Glomerular filtration rate decreased, Glucose urine absent, Glycosylated haemoglobin, Haematocrit normal
Clinical narrative: Dizziness; Tiredness; Irregular heartbeat; Joint pain; Chill; Blood in urine; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 16:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 16Apr2021 at 08:30 the patient experienced dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit and the events resulted in emergency room/department visit or urgent care. On same day, the patient underwent test for heart rate and the result was irregular heartbeat. The clinical outcome of the events dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Haemoglobin normal, Heart rate irregular, Helicobacter test, Hypoaesthesia, Immature granulocyte count
Clinical narrative: Dizziness; Tiredness; Irregular heartbeat; Joint pain; Chill; Blood in urine; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 16:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 16Apr2021 at 08:30 the patient experienced dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit and the events resulted in emergency room/department visit or urgent care. On same day, the patient underwent test for heart rate and the result was irregular heartbeat. The clinical outcome of the events dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lymphocyte count normal, Lymphocyte percentage, Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal, Mean cell volume normal
Clinical narrative: Dizziness; Tiredness; Irregular heartbeat; Joint pain; Chill; Blood in urine; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 16:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 16Apr2021 at 08:30 the patient experienced dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit and the events resulted in emergency room/department visit or urgent care. On same day, the patient underwent test for heart rate and the result was irregular heartbeat. The clinical outcome of the events dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Monocyte count normal, Monocyte percentage increased, Neutrophil count decreased, Neutrophil percentage decreased, Nitrite urine absent
Clinical narrative: Dizziness; Tiredness; Irregular heartbeat; Joint pain; Chill; Blood in urine; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 16:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 16Apr2021 at 08:30 the patient experienced dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit and the events resulted in emergency room/department visit or urgent care. On same day, the patient underwent test for heart rate and the result was irregular heartbeat. The clinical outcome of the events dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Occult blood negative, Platelet count normal, Protein total normal, Protein urine absent, Red blood cell count decreased
Clinical narrative: Dizziness; Tiredness; Irregular heartbeat; Joint pain; Chill; Blood in urine; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 16:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 16Apr2021 at 08:30 the patient experienced dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit and the events resulted in emergency room/department visit or urgent care. On same day, the patient underwent test for heart rate and the result was irregular heartbeat. The clinical outcome of the events dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Red blood cell sedimentation rate normal, Red cell distribution width normal, Serum ferritin normal, Specific gravity urine normal, Urinary casts absent
Clinical narrative: Dizziness; Tiredness; Irregular heartbeat; Joint pain; Chill; Blood in urine; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 16:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 16Apr2021 at 08:30 the patient experienced dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit and the events resulted in emergency room/department visit or urgent care. On same day, the patient underwent test for heart rate and the result was irregular heartbeat. The clinical outcome of the events dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Urinary sediment present, Urine analysis, Urine ketone body absent, Urobilinogen urine, Vitamin B12 normal
Clinical narrative: Dizziness; Tiredness; Irregular heartbeat; Joint pain; Chill; Blood in urine; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 16:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 16Apr2021 at 08:30 the patient experienced dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit and the events resulted in emergency room/department visit or urgent care. On same day, the patient underwent test for heart rate and the result was irregular heartbeat. The clinical outcome of the events dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vitamin D, White blood cell count decreased
Clinical narrative: Dizziness; Tiredness; Irregular heartbeat; Joint pain; Chill; Blood in urine; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 16:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 16Apr2021 at 08:30 the patient experienced dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit and the events resulted in emergency room/department visit or urgent care. On same day, the patient underwent test for heart rate and the result was irregular heartbeat. The clinical outcome of the events dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Blood urine present, Chills, Dizziness, Fatigue
Clinical narrative: Dizziness; Tiredness; Irregular heartbeat; Joint pain; Chill; Blood in urine; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 16:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 16Apr2021 at 08:30 the patient experienced dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit and the events resulted in emergency room/department visit or urgent care. On same day, the patient underwent test for heart rate and the result was irregular heartbeat. The clinical outcome of the events dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Heart rate, Heart rate irregular
Clinical narrative: Dizziness; Tiredness; Irregular heartbeat; Joint pain; Chill; Blood in urine; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 16:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 16Apr2021 at 08:30 the patient experienced dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit and the events resulted in emergency room/department visit or urgent care. On same day, the patient underwent test for heart rate and the result was irregular heartbeat. The clinical outcome of the events dizziness, tiredness, irregular heartbeat, joint pain, chill and blood in urine were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Aphasia, Arthralgia, Balance disorder, Dizziness, Dyskinesia
Clinical narrative: covid positive detected; covid positive detected; This is a spontaneous report from a contactable consumer (patient). A 22-year-old patient of an unspecified gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in right arm on 14May2021 at 10:45 (Batch/Lot Number: EW0171) at the age of 22-years-old  as dose 2, single, and first dose via an unspecified route of administration, administered in right arm on 23Apr2021 at 10:45 (Batch/Lot Number: ER8932) as dose 1, single for COVID-19 immunisation.  Medical history included hypothyroidism from 2010 and ongoing (Managed with medication), seasonal allergy from 2010 and ongoing (Managed with medication), migraine from 2016 and ongoing (Managed with medication). Concomitant medications included levothyroxine sodium (UNITHROID) taken for hypothyroidism from 2010 and ongoing; cetirizine hydrochloride (ZYRTEC) taken for seasonal allergy, hypersensitivity from 2010 and ongoing.  The patient experienced covid positive detected on 01Sep2021. The outcome of event was unknown.   No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Gait disturbance, Hemiparesis, Humidity intolerance, Hypoaesthesia, Muscle spasms
Clinical narrative: covid positive detected; covid positive detected; This is a spontaneous report from a contactable consumer (patient). A 22-year-old patient of an unspecified gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in right arm on 14May2021 at 10:45 (Batch/Lot Number: EW0171) at the age of 22-years-old  as dose 2, single, and first dose via an unspecified route of administration, administered in right arm on 23Apr2021 at 10:45 (Batch/Lot Number: ER8932) as dose 1, single for COVID-19 immunisation.  Medical history included hypothyroidism from 2010 and ongoing (Managed with medication), seasonal allergy from 2010 and ongoing (Managed with medication), migraine from 2016 and ongoing (Managed with medication). Concomitant medications included levothyroxine sodium (UNITHROID) taken for hypothyroidism from 2010 and ongoing; cetirizine hydrochloride (ZYRTEC) taken for seasonal allergy, hypersensitivity from 2010 and ongoing.  The patient experienced covid positive detected on 01Sep2021. The outcome of event was unknown.   No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Muscle twitching, Myalgia, Neuralgia, Palpitations, Paraesthesia
Clinical narrative: covid positive detected; covid positive detected; This is a spontaneous report from a contactable consumer (patient). A 22-year-old patient of an unspecified gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in right arm on 14May2021 at 10:45 (Batch/Lot Number: EW0171) at the age of 22-years-old  as dose 2, single, and first dose via an unspecified route of administration, administered in right arm on 23Apr2021 at 10:45 (Batch/Lot Number: ER8932) as dose 1, single for COVID-19 immunisation.  Medical history included hypothyroidism from 2010 and ongoing (Managed with medication), seasonal allergy from 2010 and ongoing (Managed with medication), migraine from 2016 and ongoing (Managed with medication). Concomitant medications included levothyroxine sodium (UNITHROID) taken for hypothyroidism from 2010 and ongoing; cetirizine hydrochloride (ZYRTEC) taken for seasonal allergy, hypersensitivity from 2010 and ongoing.  The patient experienced covid positive detected on 01Sep2021. The outcome of event was unknown.   No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Sensory disturbance, Temperature intolerance, Vision blurred
Clinical narrative: covid positive detected; covid positive detected; This is a spontaneous report from a contactable consumer (patient). A 22-year-old patient of an unspecified gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in right arm on 14May2021 at 10:45 (Batch/Lot Number: EW0171) at the age of 22-years-old  as dose 2, single, and first dose via an unspecified route of administration, administered in right arm on 23Apr2021 at 10:45 (Batch/Lot Number: ER8932) as dose 1, single for COVID-19 immunisation.  Medical history included hypothyroidism from 2010 and ongoing (Managed with medication), seasonal allergy from 2010 and ongoing (Managed with medication), migraine from 2016 and ongoing (Managed with medication). Concomitant medications included levothyroxine sodium (UNITHROID) taken for hypothyroidism from 2010 and ongoing; cetirizine hydrochloride (ZYRTEC) taken for seasonal allergy, hypersensitivity from 2010 and ongoing.  The patient experienced covid positive detected on 01Sep2021. The outcome of event was unknown.   No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: covid positive detected; covid positive detected; This is a spontaneous report from a contactable consumer (patient). A 22-year-old patient of an unspecified gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in right arm on 14May2021 at 10:45 (Batch/Lot Number: EW0171) at the age of 22-years-old  as dose 2, single, and first dose via an unspecified route of administration, administered in right arm on 23Apr2021 at 10:45 (Batch/Lot Number: ER8932) as dose 1, single for COVID-19 immunisation.  Medical history included hypothyroidism from 2010 and ongoing (Managed with medication), seasonal allergy from 2010 and ongoing (Managed with medication), migraine from 2016 and ongoing (Managed with medication). Concomitant medications included levothyroxine sodium (UNITHROID) taken for hypothyroidism from 2010 and ongoing; cetirizine hydrochloride (ZYRTEC) taken for seasonal allergy, hypersensitivity from 2010 and ongoing.  The patient experienced covid positive detected on 01Sep2021. The outcome of event was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: Rash on left forearm, left middle finger, and smaller rash on abdomen; This is spontaneous report from a contactable consumer (patient) reported himself. A 52-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot number: EW0196) via an unspecified route, administered in right arm on 26Jun2021 at 15:30 (at the age of 52-years-old) as dose 1, single for COVID-19 immunization at pharmacy/drug store. The patient's medical history and concomitant medication were not reported. The patient previously took a course of Doxycycline in Apr2021 that he was prescribed, and he was allergic to it. It was the first time in his life he has been allergic to anything. He started a different antibiotic. Now he had a reaction to the COVID vaccine. He did not know if it was related. The Doxycycline was in an amber coloured pharmacy bottle. The additional vaccines administered on same date of the Pfizer suspect and list all vaccines administered on same date with the Pfizer vaccine considered as suspect were none. Prior vaccinations within 4 weeks and other vaccinations within four weeks prior to the first administration date of the suspect vaccine were none. Adverse events following prior vaccinations was none. Other relevant medical history, Illness/adverse event was none. Family medical history relevant to adverse event was none. His father got the Pfizer vaccine, and he had no problems. His mother had the Moderna and she felt sick after but had no real problem. He had a question. He asked if he should get the second dose of the COVID vaccine. On 01Jul2021, started about 5 days after he had the injection, he had rash on left fore-arm, left middle finger, and smaller rash on abdomen. He had a rash in an area away from the injection site. He did not visit emergency room and physician office. He did not really know who his physician was. He just switched insurance and he was not sure who it was. He was left-handed. Relevant test was none. The outcome of the event was not recovered.  Follow-up attempts were completed. No further information was expected.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test normal, Cardiac stress test, Chest pain, Dyspnoea, Dyspnoea exertional
Clinical narrative: Pronounced awareness of heartbeat; irregular heartbeat; significant increase in tiredness; shortness of breath during minor tasks; periodic dull pain in chest; loss of ability to perform cardio exercise; This is a spontaneous report from a contactable consumer. This 63-year-old male consumer (Patient) reported that:  A 63-years-old male patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: ER8727), via an unspecified route of administration, administered in Arm Left on 27Mar2021 (At the age of 63 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient previously received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN6205), via an unspecified route of administration, administered in Arm Left on 06Mar2021 (At the age of 63 years) as DOSE 1, SINGLE for covid-19 immunisation. No known allergies. Medical history included myocardial ischemia from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included Atorvastatin (40 mg) and Tamsulosin (.4 mg) taken for an unspecified indication, start and stop date were not reported. On 03Apr2021, the patient had experienced Pronounced awareness of heartbeat, irregular heartbeat, significant increase in tiredness, shortness of breath during minor tasks, periodic dull pain in chest, loss of ability to perform cardio exercise. Symptoms started about 1 week after second dose and have increased since then.The patient underwent lab tests and procedures which included heart rate: irregular on 03Apr2021. No treatment was received in response to the adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. At the time of reporting, the outcome of the events were not recovered.  Follow-up attempts are completed. No further information is expected.